Immatics Price Fair Value from 2010 to 2024

IMTXW Stock  USD 0.50  0.10  25.00%   
Immatics Biotechnologies Price Fair Value yearly trend continues to be fairly stable with very little volatility. Price Fair Value is likely to outpace its year average in 2024. During the period from 2010 to 2024, Immatics Biotechnologies Price Fair Value regression line of quarterly data had mean square error of  302.60 and geometric mean of  22.07. View All Fundamentals
 
Price Fair Value  
First Reported
2010-12-31
Previous Quarter
3.40907057
Current Value
3.58
Quarterly Volatility
30.04326837
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immatics Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 13.7 M or Interest Income of 14.5 M, as well as many indicators such as Price To Sales Ratio of 13.5, Dividend Yield of 0.0 or PTB Ratio of 3.58. Immatics financial statements analysis is a perfect complement when working with Immatics Biotechnologies Valuation or Volatility modules.
  
Check out the analysis of Immatics Biotechnologies Correlation against competitors.

Latest Immatics Biotechnologies' Price Fair Value Growth Pattern

Below is the plot of the Price Fair Value of immatics biotechnologies GmbH over the last few years. It is Immatics Biotechnologies' Price Fair Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immatics Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Price Fair Value10 Years Trend
Slightly volatile
   Price Fair Value   
       Timeline  

Immatics Price Fair Value Regression Statistics

Arithmetic Mean(28.96)
Geometric Mean22.07
Coefficient Of Variation(103.76)
Mean Deviation27.24
Median(51.66)
Standard Deviation30.04
Sample Variance902.60
Range82.558
R-Value0.83
Mean Square Error302.60
R-Squared0.69
Significance0.0001
Slope5.57
Total Sum of Squares12,636

Immatics Price Fair Value History

2024 3.58
2023 3.41
2022 2.57
2021 30.9
2020 4.06
2019 -13.94

About Immatics Biotechnologies Financial Statements

Immatics Biotechnologies investors use historical fundamental indicators, such as Immatics Biotechnologies' Price Fair Value, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immatics Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Fair Value 3.41  3.58 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immatics Stock Analysis

When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.